Lyrica®: Filling a pain gap or emerging threat?

Use of pregabalin (sold as Lyrica®) has skyrocketed in recent years.

Anecdotal reports indicate problematic use is becoming more common including amongst people who inject drugs.

In Australia, pregabalin is a commonly prescribed medicine, subsidised as an anti-epileptic and to treat neuropathic pain.

It is often prescribed for the treatment of other conditions including musculoskeletal pain and generalised anxiety disorder. It is an effective medicine and has an important role in managing pain.

This seminar will discuss pregabalin, its benefits, potential for misuse and methods to reduce harms.

This pregabalin seminar is your opportunity to hear from the experts, ask questions and learn from each other.